期刊文献+

谷氨酰胺联合丝裂霉素C对人胃癌细胞株MGC-803的作用 被引量:9

Effect of Combination of Glutamine and Mitomycin C on Human Gastric Carcinoma Cell Strain MGC-803
下载PDF
导出
摘要 目的评估谷氨酰胺(GLN)联合丝裂霉素C(MMC)对人胃癌细胞株MGC-803的作用。方法采用MTT法检测药物对细胞的作用,应用中效原理判断两药合用效果,流式细胞仪检测细胞周期分布。结果GLN无明显刺激肿瘤生长作用,但随药物浓度升高和作用时间延长,可抑制肿瘤细胞生长,并呈剂量及时间依赖性。MMC具有良好的抗肿瘤作用,呈明显的时间依赖性。GLN与MMC联用时呈较弱的拮抗作用(1<CI<1·2703)。MMC有明显的S期阻滞作用,小剂量GLN对此阻滞作用影响较小,但大剂量GLN可显著减弱S期阻滞,降低细胞增殖指数。结论GLN与MMC对胃癌细胞的疗效呈剂量相关的拮抗作用。较大剂量MMC与小剂量GLN联用效果较好。 Objective To evaluate the effect of combination of glutamine (GLN) and mitomycin C (MMC) on the human gastric carcinoma cell line MGC-803 in vitro. Methods The effects of GLN and MMC were measured by MTT assay, and the interaction between the two agents was evaluated by the median-effect principle. Flow cytometry was used for cell cycle analysis. Results GLN did not significantly stimulate the cell growth in vitro. High-concentration of GLN could inhibit the cell growth. MMC could effectively inhibit the cell growth in a time-dependent manner. The interaction of these two agents showed a weak antagonistic activity ( 1 〈 CI 〈 1. 2703 ). MMC induced remarkable S-phase arrest. Low-dose GLN has limited effect on the S-phase arrest of MMC, while high-dose GLN significantly attenuated the S-phase arrest and lowered the proliferation index of MGC-803 cell. Conclusions Combination of GLN and MMC has a a weak and dose-dependent antagonistic activity in the treatment of gastric carcinoma cell line MGC-803. The combination of high-dose MMC and low-dose GLN may achieve better efficacy.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2006年第3期345-349,共5页 Acta Academiae Medicinae Sinicae
关键词 谷氨酰胺 丝裂霉素C 药物疗法 联合 流式细胞术 glutamine mitomycin C drug therapy combination flow cytometry
  • 相关文献

参考文献7

二级参考文献24

  • 1[1]Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 1999, 80(6) :827
  • 2[2]Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 1999, 83(1) :18
  • 3[3]Nishida S, Kitamura K, Ichikawa D, et al. Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer. Anticancer Res, 2000, 20 (3B) :2155
  • 4[4]Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non- Asian patients: Revisiting a meta- analysis of randomized trials. Eur J Cancer, 1999, 35(7) : 1059
  • 5[5]Mari E, Floriani I, Tinazzi A, et al. Efficacy of adjuvant chemotherapy after curative resection for gasttric cancer: A metaanalysis of published randomized trials. Ann Oncol, 2000, 11(7) :837
  • 6[6]Panzini I, Gianni L, Fattori PP, et al. Adjuvant chemotherapy in gastric cancer: A meta- analysis of randomized trials and a comparison with previous meta- analyses. Tumori, 2002, 88(1) :21
  • 7[7]Kim R, Yoshida K, Toge T. Current status and future perspectives of post - operative adjuvant therapy for gastric carcinoma.Anticancer Res, 2002, 22 (1A) :283
  • 8[8]Cirera L, Balil A, Batiste- Alentorn E, et al. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage Ⅲ gastric cancer. J Clin Oncol, 1999, 17 (12):3810
  • 9[9]Takiguchi N, Fujimoto S, Koda K, et al. Postoperative adjuvant chemotherapy iseffective in gastric cancer with serosal invasion: significance in patients chosen for multivariate analysis.Oncol Rep, 2002, 9 (4) :801
  • 10[10]Chang HM, Jung kh, Kim TY, et al. A phase Ⅲ randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5 - fluorouracil and mitomycin C versus 5- fluorouracil alone in curatively resected gastric cancer. Ann Oncol, 2002, 13 (11) :1779

共引文献43

同被引文献73

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部